Acetylcholine
receptors that bind nicotine with high affinity but do not bind a-abungarotoxin have recently been immunoaffinity purified from brains of chickens and rats (Whiting and Lindstrom, 1988a, b; Whiting and Lindstrom, 1987a) . Antisera to these receptors bind to the nicotinic receptors that regulate cation channel opening on chick ciliary ganglion neurons (Stollberg et al., 1986) and rat PC12 cells (Whiting et al., 1987~ The nicotinic acetylcholine receptors (AChRs) from both electric organ and skeletal muscle have been purified and extensively characterized, in large part because of 2 gifts of nature: fish electric organs and snake toxins (for reviews, see Popot and Changeux, 1984, and McCarthy et al., 1986) . Electric organs provide a rich source of AChR, and a-bungarotoxin (aBgt) provides a biochemical probe with very high affinity for the ACh binding site of these AChRs. Monoclonal antibodies (mAbs) have proven to be equally powerful tools for studying AChRs, providing valuable information on AChR structure, function, biosynthesis, development, and autoimmune response (for reviews, see Lindstrom, , 1986a . By contrast, nicotinic AChRs in the central nervous system have remained far more elusive for lack of comparable gifts of nature. Very small amounts of AChR are present in brain. Neuronal bungarotoxin is a component of Bungarus multicinctus venom, which, unlike cuBgt, binds to neuronal nicotinic AChRs. However, neuronal bungarotoxin is present in smaller amounts than otBgt, has lower affinity and specificity, and has only recently been 1251-labeled (Chiapinelli, 1983 (Chiapinelli, , 1985 Berg, 1986, 1987; Smith et al., 1986; Chiapinelli et al., 1987) . The absence of suitable biochemical probes has recently been compensated for by technical advances in the form of mAb probes (Whiting and Lindstrom, 1986a, b, 1987a, b) and cDNA probes (Boulter et al., 1986; Goldman et al., 1986 Goldman et al., , 1987 .
Although cYBgt binding sites are found in the nervous system, their physiological role is unclear. otBgt blocks neuronal AChR function in the cockroach (Sattelle et al., 1983) , toad, and goldfish (Freeman et al., 1980) but has no effect on AChRs in rat cervical ganglion (Brown and Fumagalli, 1977) rat PC12 cells (Patrick and Stallcup, 1977) , chick ciliary ganglion neurons (Carbonetto et al., 1978; Kouvelas et al., 1978; Ravdin and Berg, 1979; Chiappinelli, 1983) , or cat carotid bodies (Gonzales et al., 1986) . The cYBgt binding protein has been purified from brains of chickens (Conti-Tronconi et al., 1985) and rats (Kemp and Morley, 1986; Whiting and Lindstrom, 1987a) . The aminoterminal amino acid sequence homology of one of its subunits with the subunits of muscle AChR (Conti-Tronconi et al., 1985) indicates that it is a member of the nicotinic AChR gene family.
While searching for useful mAb probes for neuronal AChRs, we found that mAb 35, raised against AChRs from electric organ (Tzartos et al., 198 l) , specifically binds cells in the lateral spiriform nucleus and optic tectum of chick brains (Swanson et al., 1983) . mAb 35 also binds to synaptic sites on chick ciliary ganglion cells (Jacob et al., 1984 (Jacob et al., , 1986 . By contrast, CuBgt binds to extrasynaptic regions on these cells (Jacob and Berg, 1983) . The ganglionic component that binds mAb 35 has the biochemical properties expected of an AChR (Smith et al., 1985) , its amount can be modulated by cholinergic ligands (Smith et al., 1986) and it binds a neuronal bungarotoxin that blocks neuronal AChR function (Halvorsen and Berg, 1987) .
Using mAb 35, we subsequently purified an AChR from chicken brain by immunoaffinity chromatography (Whiting and Lindstrom, 1986a) . This AChR is an integral membrane glycoprotein approximately 10 S in size with 2 subunits: (Y (A4, 49,000) and p (Mr 59,000). The o( subunit binds both antisera and a mAb (2 10) specific for a a subunits of AChRs from electric organ and skeletal muscle. This AChR reversibly binds nicotinic ligands, but does not bind otBgt, and it can be affinity-labeled with bromoacetylcholine (BAC) and 4-(N-maleimido)benzyltrimethylammonium iodide (MBTA) (Whiting and Lindstrom, 1986b, 1987b) . Antisera raised in rats against the AChR from chicken brain specifically block the ACh-induced depolarization of chick ciliary ganglion cells in culture (Stollberg et al., 1986) , showing that the antibodies bind to a physiologically significant AChR.
However, mAb 35 binds only negligibly to nicotinic AChRs from the brains of rats (Whiting and Lindstrom, 1986b ) and thus cannot be used for their purification and characterization. In addition, we only had one subunit-specific mAb (mAb 2 10) that cross-reacted with AChRs from chicken brains. Thus, mAbs were prepared to AChRs from chicken brains with the aim of producing additional biochemical probes to AChRs from chicken brain, and probes that would also allow the location, purification, and characterization of homologous AChRs from rat brain. These aims have been achieved (Whiting and Lindstrom, 1986b, 1987a, b; Swanson et al., 1987; Whiting et al., 1987a, b) .
Here we report the production and characterization of subunit-specific mAbs to AChRs from chicken brain, and use these mAbs to demonstrate homologies between AChR subunits, to investigate the stoichiometries of subunits in the AChR macromolecule, and to discover the existence of structurally distinct AChR subtypes in chicken brains.
Materials and Methods
AChR pur#ication. AChRs from chicken brain were purified by immunoaffinity chromatography using mAb 35 or mAb 270 coupled to Sepharose CL4B (at 10 or 8 mg/ml, respectively), as previously described (Whiting and Lindstrom, 1986a, 1987a) . Purified AChR was radioiodinated essentially as described previously (Whiting and LindStrom, 1986a ). Briefly, AChR from 100 brains (obtained from Pel-Freez Biologicals) was purified through 2 rounds of immunoaffinity chromatography, eluted from the second-antibody column in a pH 3.0 buffer containing 0.05% Tween-20 detergent, and then concentrated and desalted to a final volume of approximately 100 ~1 using a Centricon 30 (Amicon) microconcentrator.
The purified AChR, 5-10 pmol, was then radioiodinated using the lactoperoxidase-glucose oxidase method (BioRad), and kept at 4°C in 10 mM Na phosphate, pH 7.5, 100 mM NaCl (PBS) containing 0.5% Triton X-100, 10 mM sodium azide, and 10 mg/ml &lactoglobulin.
Detergent extracts of Torpedo, rat, bovine and human brains, and chick muscle were also prepared as previously described (Whiting and Lindstrom, 1986a) . Human brain was obtained through the courtesy of Dr. Robert Terry. AChR from Torpedo electric organ was affinity-purified by standard techniques (Lindstrom et al., 198 1) .
Immunization and fusions. Female Lewis rats (6-8 weeks old) received intramuscular injections of purified chicken brain AChR, both intact and SDS-denatured, emulsified in 1 O&200 ~1 of complete Freund's adjuvant (CFA). Details of the immunization schedules are given in Table 1 . The rats were killed and their spleen cells fused with the mouse myeloma cell line S 194 1 S.XXO.BU. 1, using 50% polyethylene glycol 4000 (Merck) as described in detail elsewhere (Hochschwender et al., 1985) . Culture supernatants were initially screened by solid-phase immunoassay using immobilized affinity-purified AChR from chicken brain (Whiting and Lindstrom, 1986a) . Hybridoma supematants, which were positive in this assay, and which, upon rescreening, exhibited binding to AChRs labeled with 'H-nicotine in detergent extracts of chicken brain (see below) and/or binding to subunits on western blots of purified AChR from chicken brain, were selected for recloning. Hybridoma cells were cloned directly in agarose (Hochschwender et al., 1985) and then grown in bulk in Iscove's medium containing 1% fetal calf serum. Supematants from mass cultures were concentrated to about 300 ml using a Millipore Minitan concentrator, and the immunoglobulin fraction isolated by precipitation with 18% sodium sulfate and then dialyzed against PBS containing 10 mM NaN,. Immunoglobulin class and subclass were determined by the Ouchterlony technique using anti-rat immunoglobulin subclass antisera (Miles). mAb 270 was purified as previously described (Whiting and Lindstrom. 1987a) . and mAb 285 was vurified bv hiahperform&ice liquid chromatography (HPLC) on a hydroxylapa&e &l-umn (BioRad).
Antibody-binding assays. 1. Solid-phase immunoassay: Cell culture supematants were screened by solid-phase immunoassay (Whiting and Lindstrom, 1986a) . Briefly, affinity-purified AChR from chicken brain (lo-100 fmol quantitated in terms of 1251-mAb 35 binding sites) in 30 pl ofPBS was applied to Millipore Millititer 96-well nitrocellulose plates and incubated overnight at 4°C. The plates were quenched for 30 min at room temperature with 50 ~1 of PBS containing 1% bovine serum albumin and 0.2% Tween-20 (quench buffer), and then 100 ~1 of culture supematant was added, followed by overnight incubation at 4°C. Plates were then washed twice with 300 ~1 of quench buffer and incubated for 2 hr at room temperature with 10 nM 1251-goat anti-rat IgG (2-3 x 10-l* cpm/mol). After 2 further washes, the nitrocellulose disks were punched out, and bound radioactivity determined by gamma counting. Nonspecific binding was determined by incubation with control culture supernatant.
2. 'H-nicotine binding assay: Antibody binding to AChRs in crude detergent extracts of brain was determined as described previously (Whiting and Lindstrom, 1986b) . Briefly, detergent extract (200-500 ~1) was shaken gently for 15 hr at 4°C with 100 ~1 of culture supematant, diluted mAb, or serum, and 20-30 ~1 of a 1:l slurry of goat anti-rat IgG Sepharose (8-12.5 mg IgG/ml gel). After washing twice with 1 ml of PBS containing 0.5% Triton X-100, the aliquots were incubated for 15 min at room temperature in 20 nM 3H-nicotine m-N-methyl 'Hnicotine, sp act 68.6 Ci/mmol, (obtained from NEN) in the same buffer, and then washed rapidly 4 times at 4°C with 1 ml of ice-cold PBS, 0.5% Triton X-100 by resuspending in the buffer and centrifuging for 20 set at 10,000 x g in a microfuge. Bound protein was then eluted by incubating the ael for 15 min with 100 ul of 2.5% SDS. 51 B-mercavtoethanol, and then sampling into 5 ml of scintillant [5% Biosolve (Beckman), 4% Liquifluor (NEN) in toluene]. Radioactivity was determined by scintillation counting. Specific binding was determined by the subtraction of binding in the absence of antibody.
Polyacvylamide gel electrophoresis and western blot analysis. SDS-PAGE and western blotting of protein samples were performed as previously described (Whiting and Lindstrom, 1986a) . with the exception that when probing' western blots with antibodies, 'all incubations-were carried out in PBS. 0.5% Triton X-100 buffer. which contained 5% (wt/ vol) milk powder (Carnation) rather than bovine serum albumin.
Results
Making a library of mAbs to AChRs from chick brain A library of 8 mAbs to nicotinic AChRs from chicken brain was prepared from rats immunized with AChRs imunoaffinitypurified using mAb 35. The preparation and properties of these mAbs is shown in Table 1 . For reference, properties of mAbs 35 and 210 to AChRs from eel electric organ and mammalian muscle that were used in these studies are also listed in Table 1 .
Discovery of subtypes of chicken brain AChRs mAb 270 cross-reacted with homologous nicotinic AChRs from brains of rats (Whiting and Lindstrom, 1986b) . This mAb was coupled to Sepharose CL4B and used to immunoaffinity-purify these AChRs from rat brain (Whiting and Lindstrom, 1987a) . AChR from rat brain contains 2 types of subunits, M, 5 1,000 ((Y) and 79,000 (p). The smaller subunit is homologous to the 49,000 M, subunit of AChRs from chicken brain, since both bind antisera to LY subunits of AChR from Torpedo electric organ and mAbs 268 and 270 (Whiting and Lindstrom, 1987a ; see also Fig. 2 ). The larger subunit (M, 79,000) of the AChR from rat brain is considerably larger than the @ subunit (M, 59,000) of AChR from chicken brain. This suggested that the AChRs we had purified from rat brain using mAb 270 were not strictly homologous to the AChRs purified from chicken brain using mAb 35.
To further investigate this observation, mAb 270, coupled to Sepharose, was used to immunoaffinity-purify AChRs from chicken brain. Analysis of the purified AChR by SDS-PAGE and subsequent silver-staining led to the surprising finding of 2 subunits of the same M, as the subunits of AChR purified from chicken brain on mAb 35 Sepharose (Mr 49,000 and 59,000; Whiting and Lindstrom, 1986a) or SDS-denatured AChR (Fig. 2) . None of the mAbs inhibited the binding of )H-nicotine to AChR detergent solubilized from chicken brain. i Subunit specificity was determined by western blot analysis (Fig. 2 ). 'mAb 35 was prepared from rats immunized with AChR from Electrophoms electricus electric organ (Tzartos et al., 198 1). mAb 2 10 was prepared from rats immunized with AChR from fetal bovine muscle and the BC3H 1 muscle-like mouse cell line (Tzartos et al., 1987) . 8 mAb 35 has high affinity for the main immunogenic region on 01 subunits, a conformation-dependent epitope. As discussed in the text, mAb 35 binds weakly to denatured a subunits of AChR from Electrophorus, but not to denatured a subunits from other species. It competes for binding to native AChRs from muscle and brain with mAb 210, which is specific for the a subunit of these AChRs (Whiting and Lindstrom, 1986a; Tzartos et al., 1987) .
Whiting and Lindstrom, 1986a) , and an additional subunit, M, 75,000, which we have designated p' (Fig. 1) . The different subunit patterns observed between AChRs purified on mAb 35 and mAb 270 did not represent differences in the sources of chicken brains or differing degrees of proteolysis during separate purifications, because AChRs purified upon mAb 35 and mAb 270 from a single chicken brain detergent extract that had been divided into 2 gave the same subunit patterns. Additionally, these patterns did not result from different allelic forms of AChR expressed in individual chickens in the batch of brains used for purification because immunohistochemical labeling of thin sections of an individual chicken brain with mAb 35 and mAb 270 demonstrates that mAb 270 labels all of the areas labeled by mAb 35, plus additional areas (Swanson et al., 1987) . Further data on the identity of the fi' subunit came from probing with the mAbs the western blots of AChR purified using mAb 270-Sepharose (Fig. 2) . mAbs 284, 285, 286, and 289 exhibited binding to the 75,000 M, p' subunit. All of these mAbs also bound to intact AChRs with high affinity for nicotine, demonstrating that /3' was part of an AChR macromolecule. mAb 286 binds to both the 75,000 M, p' subunit of chicken AChR and the 79,000 M, /3 subunit of AChR from rat brain (Fig. 2 and Whiting and Lindstrom, 1987a) , showing that these are homologous subunits. mAb 267 binds strongly to both (Y and p subunits. mAb 286 binds to p' subunits and cross-reacts weakly with 01 subunits. Binding of mAbs to more than one subunit has been previously observed with mAbs to AChR from Torpedo electric organ (Gullick and Lindstrom, 1983) and probably reflects the sequence homology between subunits (Noda et al., 1983b) . To determine which subunits were associated together in the AChR macromolecule, AChR was affinity-purified on mAb 270 Sepharose, radioiodinated, and tested for binding to each of the mAbs. The AChR bound by each mAb was analyzed by SDS-PAGE and autoradiography (Fig. 3) . The results clearly suggest that 2 subtypes exist: a subtype composed of LY and 0 subunits, bound by mAb 35, and a subtype composed of o( and P' subunits, bound by mAb 284 (and also by mAbs 285 and 289; data not shown). Both subtypes are bound by mAb 270, reflecting the specificity of mAb 270 for the LY subunit, because, as is discussed below, the O( subunits of the 2 AChR subtypes are very similar, or identical.
The data presented in Figure 3 suggest that mAb 35 binds almost exclusively to the AChR subtype with @ subunits. How- . Purified protein was analyzed by SDS-PAGE on a 10% gel, followed by silver-staining. Apparent subunit molecular weights were determined using low-molecular-weight standards (BioRad) resolved on the same gel.
ever, this mAb must exhibit some binding to the AChR subtype with p' subunits because, as we have shown above, 4 mAbs directed to the p' subunit were obtained from rats immunized with AChR affinity-purified from chicken brains using mAb 3% Sepharose. To investigate the reactivity of mAb 35 with the AChR subtype characterized by p' subunits, the binding of lZ51-mAb 35, and also lZSI-mAb 270, to AChR immobilized upon mAb 285-Sepharose was determined (Fig. 4) . '%rnAb 270 binds strongly to AChRs immobilized on mAb 285Sepharose. Y-mAb 35 binds only weakly to this AChR subtype. The Kd for binding of mAb 35 to the AChR subtype characterized by p' subunits (as determined by extrapolation of the curve to the half-maximal binding) was approximately 3 5 nM, considerably greater than the Kd of 0.5 nM for binding to the AChR subtype characterized by p subunits (determined from the binding of L251-mAb 35 to solubilized AChR by DEAE assay; data shown in Whiting and Lindstrom, 1986a) . The 0' subunit must be highly immunogenic, because this polypeptide was probably only a minor component ofthe immunogen used for preparation of the mAbs (it was not visualized in silver-stained preparations of AChR purified on mAb 35), yet 4 of the 8 mAbs subsequently derived were directed against it.
Comparison of structural and ligand-binding properties of the AChR subtypes There is strong indirect evidence that mAb 35 binds to the (Y subunit of AChRs from chicken brain. mAb 35 was prepared to AChRs from electric organ (see Table 1 ). It is directed at the main immunogenic region (a domain on the extracellular surface of a subunits of AChRs from electric organ and muscle; Tzartos et al., 198 1). mAb 35 binds weakly to denatured (Y subunits of AChR from Electrophorous and competes for binding to native AChRs with mAb 210. mAb 2 10 was prepared to AChR from muscle. It binds to native AChRs and denatured (Y subunits of AChRs from electric organ (Ratnam et al., 1986) , skeletal muscle (Tzartos et al., 1987) and chicken brain (Whiting and LindStrom, 1986a) . Like mAb 35, mAb 2 10 also binds only to native chicken brain AChRs of the CY@ subtype; yet it binds to the denatured cy subunits of both subtypes on western blots (data not shown).
The differential binding of the (Y subunit-specific mAbs 35 and 210 to the AChR subtypes might reflect either differences in the amino acid sequence of the (Y subunits of the 2 AChR subtypes or differences in the conformation or accessibility of LY determinants in association with p subunit types that differ so much in size. To investigate these possibilities, peptide mapping was performed on the isolated a! subunits of each AChR subtype. AChR was immunoaffinity-purified on mAb 270 Sepharose, radioiodinated, and then the 2 subtypes were obtained by repurification on mAb 35Sepharose or mAb 285Sepharose. Subunits from each preparation were isolated by preparative electrophoresis. The a: subunits were then subjected to proteolytic digestion with Staphylococcus V8 protease (Fig. 5) . The peptide maps obtained were essentially indistinguishable, although minor differences may exist between peptides from M, 14,000 to 2 1,000. We have previously reported that peptide mapping can be used to demonstrate differences between the (Y subunits of AChRs from Torpedo electric organ and AChR from chicken brain (Whiting and Lindstrom, 1986a) . Thus, the peptide maps in Figure 5 suggest that the 2 subunits are very similar, perhaps identical. Additionally, when western blots of AChR subtypes (purified on mAb 35-and mAb 285Sepharose) were probed with mAbs directed at the (Y subunit (210, 267, 268, 270, 287) , binding to (Y subunits of both AChR subtypes was observed (data not shown). Thus, differential binding of mAb 3 5 and mAb 2 10 to native AChR subtypes is unlikely to be due to substantial sequence differences between the cy subunits of the AChRs of each subtype. The ability of mAb 35 to bind depends strongly on the conformation of the AChR, and it does not bind to denatured a! subunits of neuronal AChRs (data not shown). The association of 01 subunits with p' subunits may cause a conformation that does not bind mAbs 35 or 210, or the larger p' subunit may simply obscure the binding site for these mAbs on the cx subunit, whereas the smaller /3 subunit does not.
I -
Subunit specificity of mAbs made to AChRs from chicken brains. AChR was affinity-purified from chicken brains on mAb 270 Sepharose. Subunits were resolved by SDS-PAGE on a 10% gel, and then transferred to diazophenylthioether paper. Each lane, containing approximately 2 pmol of AChR, was probed with 150 dilution of each mAb. Bound mAbs were visualized by means of 0.5 nM lzSI-goat anti-rat IgG and autoradiography at -70°C using preflashed Kodak XAR film and a Cronex intensifying screen. Molecular-weight markers (BioRad) were resolved on the same polyacrylamide gel, the lane excised and stained for protein.
The affinity of the 2 AChR subtypes for DL-3H-nicotine was investigated by immobilizing AChRs on mAb 35-Sepharose or mAb 285Sepharose and then determining binding curves for the radioligand, as previously described (Whiting and LindStrom, 1986b) . Scatchard analysis of the binding curves (data not shown) gave superimposable plots for the 2 AChR subtypes, both with an apparent Kd of 6.2 nM (true Kd of 3.1 nM; see below), a value identical to that reported previously for AChR immobilized on mAb 35-Sepharose (Whiting and Lindstrom, 1986b) . The pharmacology of the 2 AChR subtypes, determined by inhibition of DL-3H-nicotine binding by various cholinergic ligands to AChR, immobilized upon mAb 35 or 285 coupled to Sepharose (and subsequent determination of the K, values), is also not significantly different ( Table 2 ). The correlation coefficient for the collective K, values in Table 2 is R = 0.99. Both subtypes exhibit very similar high-affinity stereospecific binding for L-nicotine. The apparent Kd for DL-3H-nicotine binding of 6.2 nM is actually 3.1 nM, since the ratio ofisomers in the racemic radioligand preparation is 1: 1 (NEN; personal communication) , and therefore the concentration of L-3H-nicotine in each assay tube was actually 50% of that added. The true Kd of 3.1 nM is, thus, in reasonable agreement with the Ki values of 1.1 and 1.6 nM for L-nicotine binding to the AChR subtypes. Others have similarly found that L-nicotine binds with much higher affinity than does D-nicotine to sites in avian and rodent brain membranes (Ki values for L-nicotine range from 2 to 6 nM, and for D-nicotine range from 120 to 146 nM; Schwartz et al., 1982; Schneider et al., 1985; Yamada et al., 1985; Lippiello and Fernandes, 1986 ).
The data from Table 2 (showing that the ligand-binding properties of the two AChR subtypes are identical) might be considered, together with the data of Figure 5 (showing that the (Y subunits of both AChR subtypes are similar or identical) and of Figure 3 (showing that the p subunits of each subtype are different), as suggesting that the ligand-binding sites were on the (Y subunits. The antigenic homologies between the (Y subunits of AChRs from electric organs, which are the ligand-binding subunits of their AChR (Kao and Karlin, 1986) , and the a! subunits of AChRs from brain ( Fig. 2; Whiting and Lindstrom, 1986a and Lindstrom, , 1987a would also suggest that the the ligand-binding sites should be found on (Y subunits of AChRs from brain. However, this is not the case.
Previously, we demonstrated that, after reduction with dithiothreitol, AChRs from chicken brain (Whiting and LindStrom, 1986b, 1987b) and ganglia (Stollberg et al., 1986) can be affinity-labeled with the reagents MBTA and BAC. This blocks nicotine binding of isolated brain AChRs and blocks the function of AChRs in cultured ganglionic neurons. Karlin and coworkers have shown that, in Torpedo AChRs, cysteines (~192 and ~~193 are linked by a disulfide bond (Kao and Karlin, 1986) , and that, after reduction of this bond, these cysteines are affinitylabeled by MBTA (Kao et al., 1984) . These results suggest that AChRs on chicken neurons that are labeled by MBTA have a cysteine pair homologous to (~192-193. In fact, when we used mAbs Figure 3 . Resolution of AChR subtypes by immunoprecipitation with mAbs. Both AChR subtypes were simultaneously affinity-purified from chicken brains using mAb 270-Sepharose. The purified AChR preparation containing both subtypes was radioiodinated. Aliquots of 3.5 x 1 O6 epm of the AChRs were incubated with mAb 270 to bind both AChR subtypes, with mAb 35 to bind the ~$3 subtype, and with mAb 284 to bind the c@' subtype, or with normal rat serum (2 ~1) as a control. They were then gently shaken for 15 hr at 4°C in 100 ~1 of PBS, 0.5% Triton X-100 containing 5% (wt/vol) nonfat milk powder with 20 pl goat antirat IgG Sepharose to precipitate the immuoecomplexes.Theimmuneprecipitates were washed 4 times with 1 ml of PBS, 0.5% Triton X-100 by pelleting in a microfuge and resuspending. Bound protein was then eluted with 60 ~1 of 125 mM Tris-HCl, pH 6.8, containing 2.3% (wt/vol) SDS, 10% (voVvo1) glycerol, and 0.005% (wt/vol) bromophenol blue. Samples were made 5% (vol/vol) in fl-mereaptoethanol. The subunits in the AChR subtypes bound by each mAb were resolved by SDS-PAGE on 10% gels, the gel dried and autoradiographed. In order to estimate the subunit ratios in each AChR subtype, the band intensities were quantitated on a scanning densitometer (Hoeffer Scientific Instruments) and the relative intensity of each subunit was expressed as a ratio, shown beneath each lane. /3 0.43 a 1.00 3H-MBTA to affinity-label AChRs from chicken brains, we found that the p and p' subunits were labeled (Whiting and Lindstrom, 1987b) . This indicates that the ACh binding sites are formed by p and /I' subunits. It suggests that such subunits contain homologs of cysteines ~~192, (~193, which has been confirmed in the case of the p subunits of rat brain by cDNA studies (see Discussion). Finally, the data of Table 2 , which show that AChRs of both subtypes have identical ligand-binding specificities, suggest that although @ and /3' subunits differ substantially in molecular weight, the parts of the extracellular portions of the p subunits that form the ACh binding site must be very similar or identical.
Developmental changes in the ratio of AChR subtypes
The proportion of these AChR subtypes in adult chicken brain was determined by quantitating the depletion of Dr?H-nicotine binding sites from brain detergent extracts by increasing concentrations of mAb 35, 270, and 285 immobilized using goat anti-rat IgG-Sepharose (Fig. 6) depleted greater than 90% of the DL-3H-nicotine binding sites (data not shown), as has been previously demonstrated (Whiting and Lindstrom, 1986b) . mAbs 35 and 285 could individually remove approximately 50% of the 3H-nicotine binding sites, but when incubated together could deplete more than 90% of the sites. These data confirm the existence of the 2 AChR subtypes, and indicate that they are present in approximately equal amounts in adult chicken brain. The proportion of these AChR subtypes in embryonic chicken brain was also investigated (Fig. 7) . As in adult chicken brain, mAb 270 depleted greater than 89% of the DL-3H-nicotine binding sites. However, the AChR subtype with p subunits (bound by mAb 35) made up a smaller proportion of the total AChRs than it did in adult brain, while the AChR subtype with p' subunits (bound by mAb 285) represented a larger proportion.
Subunit stoichiometry
In order to determine whether more than one copy of a subunit was present in an AChR macromolecule, we tested to see whether an AChR immobilized via a subunit-specific mAb was able 270 (radiolabeled by a modified chloramine-T method to specific activities of l-3 x 1O1* cpm/mol; Lindstrom et al., 198 1) . The aliquots were washed 3 times with 1 ml ofPBS containing 0.5% Triton X-100 by pelleting in a microfuge and resuspending, and bound radioactivity was determined by gamma counting. Nonspecific binding was determined by parallel incubations in the presence of excess nonradioactive mAb 35 (6 LLM) and mAb 270 (0.2 PM), and was subtracted. Each point is the mean of triplicate incubations.
to bind additional molecules of that same mAb. Figure 8 clearly indicates that for both the a-specific mAbs 35 and 270 and the P'-specific mAb 285, this was the case. Thus, the subunit stoichiometry is a&3"Zz. The number of mAb 35 binding sites immobilized upon mAb 35-Sepharose, as determined from the depletion of lZSI-mAb 35 binding sites from brain detergent extracts, as measured by the DEAE assay previously described (Whiting and Lindstrom, 1986a) , was 24.6 fmol in the experiment shown in Figure 8B . If there were 2 (Y subunits per AChR, and each AChR were immobilized through one a subunit, then 12.3 fmol of binding sites should still be available for lZ51-mAb 35 binding. In fact, 6.8 fmol of lZ51-mAb 35 were bound. Although this was less than the number oftheoretical binding sites, it clearly indicates that there is more than one (Y per AChR. The reduced number of binding sites observed could be due to binding of both (Y subunits on some AChRs by immobilized mAb, to the short incubation time with the lZ51-mAb, to steric hindrance, or to elution of immobilized AChR by the free lz51-mAb.
The chicken brain AChR macromolecule sediments on sucrose gradients at a rate intermediate between Torpedo AChR monomers (Mr 268,000 protein, -302,000 plus sugar) and dimers (A4, 536,000 protein) (Lindstrom et al., 1983; Whiting and Lindstrom, 1986a) . The calculated molecular weights of aJn, with n = 2 or 3, range between 216,000 and 323,000 for chicken brain AChRs, which is of this order, but the accuracy of these measurements does not permit a precise determination.
The ratio of subunits obtained from densitometric scanning of the autoradiograms in Figure 3 is most consistent with (Y& or (Y& stoichiometries, but this assumes that lz51 is incorporated equivalently in both subunits per unit weight. Thus, these data also fail to absolutely define the stoichiometry. L-Nicotine 1.1 x 10-v 1.6 x 1O-9 Cytisine 1.1 x 10-g 1.4 x 10-g Carbachol 8.4 x 10m8 1.4 x 10-7 Decamethonium 8.7 x 10m6 3.0 x 10-G Curare 1.1 x 10-5 3.7 x 10-6 Hexamethonium > 10-J > 10-3 Mecamylamine > 10-3 > 10-3 cuBgt > 10-e > 10-G Atropine > 10-3 > 10-J Inhibition of DL-'H-nicotine binding to AChRs immobilized upon antibodySepharose was determined as previously described (Whiting and Lindstrom, 1986b) . The K, was calculated from an experimentally determined IC,, value using the equation, K, = IC,dl + (3H-nicotinelK.). y These values were taken from Whiting and Lindstrom (1986b) , with the exception of the K, for L-nicotine.
The & or a& subunit arrangements are attractive because they would confer a 5-fold symmetry upon the receptor macromolecule, as is found for the &3yS structure of Torpedo receptor monomers (Reynolds and Karlin, 1978; Lindstrom et al., 1979; Raftery et al., 1980; Brisson and Unwin, 1984; Kubalek et al., 1987) . The a1& stoichiometry is especially appealing because it preserves the symmetry of 2 ACh-binding subunits and 3 structural subunits. However, the data are insufficient for concluding more than that the subunit stoichiometry is %=Z-3Pn=2-3. Discussion This is the first report of the production and characterization of mAbs to neuronal nicotinic AChRs that do not bind otBgt. This paper describes the use of these mAbs to identify subtypes of AChRs in chicken brains and also to further compare these neuronal AChRs with AChRs from muscle and electric organ.
It has been very important to show that the proteins we have purified and characterized using mAbs are not simply proteins present in brain that have a limited, fortuitous homology to nicotinic AChRs from electric organ and muscle, but are, in fact, functional neuronal nicotinic AChRs. Many pieces of evidence now indicate that these proteins are neuronal nicotinic ACh receptors: (1) They have a nicotinic cholinergic pharmacology (Whiting and Lindstrom, 1986b Lindstrom, , 1987b ; (2) they do not bind LvBgt (Whiting and Lindstrom, 1986a) , a ligand about which there is much evidence demonstrating that it does not bind to functional neuronal AChRs in the chicken and mammalian brain (as discussed more fully below); (3) the ACh binding site of these neuronal AChRs, like those of AChRs from electric organ and muscle (see Popot and Changeux, 1984 ) has a reducible disulfide bond in close proximity that can be labeled with cholinergic affinity reagents (Whiting and Lindstrom, 1987b) ; (4) antisera prepared to AChRs purified from chicken brain specifically blocked the ACh-induced depolarization of chick ciliary ganglion cells in culture (Stollberg et al., 1986) ; (5) mAb 270, and also polyclonal antisera to AChRs from chicken brain, could antigenically modulate the functional AChR on rat PC 12 cells 1 2 3 4 5 6 7 8 910 Figure 5 . Peptide maps of the a subunits of both AChR subtypes. AChR was immunoaffinity-purified from chicken brains through 2 rounds of affinity-chromatography on mAb 270-Sepharose, radioiodinated, and the 2 AChR subtypes isolated using mAb 35-and mAb 285Sepharose, according to the method described in the legend to Figure 3 . The AChR polypeptides were resolved by SDS-PAGE on a 10% gel and the subunits located by autoradiography of the wet gel. The polypeptides were eluted from gel slices, as described previously (Whiting and Lindstrom, 1986a) ,-and their purity checked bv re-electroohoresis. Diaestion of isolated 01 subunits with St&h-ylococcus V8 protease and resolution of the fragments by 15% SDS-PAGE has been described previously (Whiting and Lindstrom, 1986a) . The peptide maps were detected by autoradiography. Schwartz et al., 1982) . Briefly, 100 ~1 triplicate aliquots were incubated for 1 hr at 4°C with 20 nM 3H-nicotine and then diluted with 4 ml of ice-cold 50 mM Tris. DH 7.4. and filtered through Whatman GF/B filters presoaked in 0.3% polyethileneimine. The fil&s were washed 3 times with 4 ml of the same buffer and bound radioactivity determined by scintillation counting. Nonspecific binding was determined by incubation in the presence of 1 mM nonradioactive nicotine, and has been subtracted. The total DL-3H-nicotine binding sites (considered 100%) were determined by incubation with goat anti-rat IgGSepharose alone, and all values were expressed relative to this.
(Whiting et al., 1987b); (6) the N-termini of their subunits show homology to subunits of AChRs from electric organ and skeletal muscle (Whiting et al., 1987c , and unpublished observations). An alternative and complementary approach to identifying and characterizing neuronal nitocinic AChRs has been taken by Patrick and Heinemann and their coworkers. They have screened cDNA libraries prepared from PC12 cells and rat brain at low stringency with probes constructed from mouse muscle AChR (Y subunit cDNA in an attempt to isolate cDNA clones coding for subunits of neuronal nicotinic AChRs. A similar approach to isolating cDNAs from chicken brain has been taken by Ballivet and coworkers (Nef et al., 1986) . Patrick and coworkers isolated a putative neuronal AChR (Y subunit cDNA clone from PC12 cells (XPCA48, now referred to as QJ with significant sequence homology to muscle AChR a! subunits (Boulter et al., 1986) . Treatment of PC12 cells with PNGF induced a parallel increase in functional AChRs and binding sites for mAb 270, but neither the number of olBgt binding sites nor the amount of mRNA that hybridizes with hPCA48 was increased by @NGF treatment (Whiting et al., 1987b) . These results suggest that synthesis of PC12 AChR may not be regulated at the level of transcription of aj, or that cu, may not code for an AChR subunit, but may code for a subunit of the cllBgt binding component. More recently, Patrick and coworkers have isolated from rat brain a second cDNA clone, LYE (Goldman et al., 1987) . We had previously determined the N-terminal amino acid sequence of the M, 79,000 /3' subunit of AChRs purified from rat brain, and this was identical to residues 27-43 of cDNA clone Q~, indicating that ad codes for the @' subunit of the nicotinic AChR from rat brain (Whiting et al., 1987~) . Thus, immunochemical, biochemical, and cDNA techniques are complementary, and the bio- Many of the mAbs prepared to AChRs from chicken brain (and also polyclonal antisera to these AChRs) exhibited crossreactivity with high-affinity nicotine binding sites in the brains of several other animal species, demonstrating that homologous neuronal nicotinic AChRs are found in other vertebrate organisms. The binding to AChRs from Torpedo brain was also investigated, using mAb 35 and mAbs to AChRs from chicken brain and rat brain (P. Whiting and J. Lindstrom, unpublished observations), but we were unable to demonstrate the presence of any high-affinity 'H-nicotine binding sites in detergent extracts, which suggests that AChRs with this pharmacological property have not evolved in elasmobranchs. Neuronal nicotinic AChRs of the ganglionic type, with similar antigenic structure (Stollberg et al., 1986; Whiting et al., 1987b) but low affinity for ACh and nicotine (Halvorsen and Berg, 1986; Kemp and Morley, 1986) Chicken brain detergent extract (200 ~1) was gently shaken for 15 hr at 4°C with 15 ~1 of a 1: 1 slurry of mAb 35-Sepharose, mAb 27O-Sepharose, and mAb 285Sepharose. The aliquots were washed with 1 ml PBS, 0.5% Triton X-100, and then incubated for 1 hr at 22°C in 100 ul PBS. 0.5% Triton X-100 containina increasing concentrations of 1251-labeled'mAb 35 (2.2 x lOI8 cpm/molL mAb 270 (0.94 x lOI* cpm/mol), and mAb 285 (3.9 x lOi cpm/mol), radiolabeled by a modified chloramine-T method (Lindstrom et al., 1981) . Parallel incubations were carried out in which aliquots were preincubated for 30 min with excess nonradioactive mAb (final concentrations: 6 PM mAb 35, 0.25 PM mAb 270, and 0.28 PM mAb 285 before addition of 1251-labeled mAb). The aliauots were washed 4 times with 1 ml PBS, 0.5% Triton X-160 by pelleting in a microfuge and resuspending, and bound radioactivity was determined by gamma counting. Data points are the mean of triplicate incubations. Specific binding (B) is the difference between binding of lZSI-mAb in the absence of competing nonradioactive mAb (A) and binding in the presence of competing nonradioactive mAb (0). any binding to AChRs solubilized from chick muscle (Table 1) . This dearth of immunological cross-reactivity between AChRs of brain and muscle, which we have previously noted with polyclonal sera raised to chicken brain AChRs (Whiting and LindStrom, 1986a) , and have also observed with mAbs prepared to AChRs from rat brain (Whiting et al., 1987a, and unpublished observations) , suggests that these AChRs have diverged substantially in their evolution from AChRs of muscle. This might be expected if the 2-subunit structure of these neuronal AChRs evolved by gene duplication from the subunit of the same primordial homopolymer AChR that evolved through repeated gene duplication along a different lineage of this gene family to produce the a,&6 subunit structure of AChRs in muscle (Raftery et al., 1980; Noda et al., 1983b) . The c&S subunit structure of AChRs from muscle was well established by the time of primitive elasmobranchs and has changed little since, as indicated by the 80% sequence homology between the LY subunits of AChRs from Torpedo electric organ and human muscle (Noda et al., 1983a, b) . By contrast, evolution of the neuronal nicotinic AChR lineage appears to have continued quite rapidly from the time of the cartilaginous fishes. We found no high-affinity nicotinic AChR in Torpedo brains. Brains ofgoldfish contain both AChRs with high affinity for cuBgt and mAbs to the main immunogenic region (Henley et al., 1986a, b) and AChRs with high affinity for nicotine but no affinity for cuBgt or mAbs to the main immunogenic region (Henley and Oswald, 1987 ; J. Henley, J. LindStrom, and R. Oswald, unpublished observations). Brains of chickens contain AChRs with high affinity for nicotine, both of a type that binds mAbs to the main immunogenic region and of a type that does not (as shown here). Chicken brains also contain c-rBgt binding components with subunits having sequence homology to AChR subunits (Conti-Tronconi et al., 1985) , so this protein must also be a part of the AChR gene family. Chicken ciliary ganglion contains AChRs that bind mAbs to the main immunogenic region, but that have low affinity for nicotine (Halvorsen and Berg, 1986) . Brains of rats have AChRs with high affinity for nicotine, but only of the subtype that does not significantly bind mAbs to the main immunogenic region (Whiting and Lindstrom, 1987a) . Ganglionic-type AChRs from rats have low affinity for nicotine and do not bind mAbs to the main immunogenic region (Whiting et al., 1987b) . High-affinity nicotinic AChRs can also be detected in detergent extracts of brains from cattle and humans, using mAbs prepared against AChRs from rat brain, and these AChRs also do not bind antibodies to the main immunogenic region (Whiting et al., 1987a, and unpublished observations) .
The possibility that additional AChR subtypes with high affinity for nicotine also exist but represent less than 10% of the total 3H-nicotine binding sites cannot be discounted. As discussed above, brain and ganglionic AChRs share several immunological determinants (Smith et al., 1985; Stollberg et al., 1986) , but ganglionic AChRs have much lower affinity for cholinergic agonists (Halvorsen and Berg, 1986; Kemp and Morley, 1986) and differ from brain AChRs in their order of reaction with the affinity-labeling reagents MBTA and BAC (compare Leprince, 1983, with Whiting and Lindstrom, 1987b) . Ganglionic AChRs are thus very similar to, but different from, brain AChRs, and can be considered another subtype of neuronal AChR. Low-stringency hybridization with cloned muscle AChR subunit cDNAs may identify several other AChR subunit homologs that may be components of neuronal nicotinic AChR subtypes (Goldman et al., , 1987 . The CyBgt binding protein of brain and ganglia may also be a more distant relative in this extended family of neuronal AChRs (Conti-Tronconi et al., 1985) . The function of this molecule is not known. In rat cervical ganglia (Brown and Fumagalli, 1977) , rat PC12 cells (Patrick and Stallcup, 1977) , chick ciliary ganglion neurons (Ravdin and Berg, 1979; Chiappinelli, 1983) , rat coeruleus neurons (Egan and North, 1986) , and cat carotid bodies (Gonzalez et al., 1986) , this molecule clearly is not an ACh-regulated cation channel.
It is likely that the 75,000 M, /3' subunit of AChRs from chicken brain is homologus to the 79,000 p' subunit of AChRs from rat brain because (1) mAb 286 exhibits strong binding to both ofthese subunits (Whiting and Lindstrom, 1987a) , (2) mAb 299, raised to AChRs from rat brain, also binds specifically to these 2 subunits (Whiting and Lindstrom, unpublished observations), (3) both these subunits are affinity-labeled with 'H-MBTA, indicating that they contain the ACh binding site (Whiting and Lindstrom, 1987b) , and (4) N-terminal amino acid sequence data indicate that the N-terminal of the 75,000 M, @' subunit of AChR from chicken brain (unpublished observations) has 88% sequence homology with the N-terminal of the 79,000 M, /3' subunit of AChR from rat brain (Whiting et al., 1987~) . The 59,000 M, p subunit of the CUB AChR subtype from chicken brain is also affinity labeled with 3H-MBTA (Whiting and Lindstrom, 1987b) , indicating that it is the ACh binding subunit of the cup AChR subtype.
It is quite striking that the 2 nicotinic AChR subtypes described here differ by 16,000 in the apparent molecular weight of their p subunits (Fig. 3) , which contain their ACh binding sites (Whiting and Lindstrom, 1987b ), yet have the same high affinity for nicotine (Table 2 ). This could be explained if the amino acid sequence of the 2 subunits were quite similar except for the insertion of an additional domain in the /3' subunits at a point away from the ACh binding site. Muscarinic M, and M, AChRs offer an interesting comparison. cDNAs for these AChRs have been sequenced (Kubo et al., 1986a, b) and shown to be highly homologous except for one stretch of 127-152 amino acids that is unique to each AChR subtype. Similarly, the sequence of the p' subunit of nicotinic AChRs from rat brain (Goldman et al., 1987) shows extensive homology with that of (Y subunits of muscle AChRs in the region from the N-terminus to about ~~333, but then exhibits little or no homology with the next 19 1 amino acids before a C-terminal region with some homology to (Y subunits. Examples of segmental homology between AChRs may predict the sequence relationship between the p and p' subunits of the 2 AChR subtypes we have identified in chick brain.
The heterogeneity of neurotransmitter receptors is well known. As examples, the opioid receptor (Paterson et al., 1983) , muscarinic AChR (Hoss and Ellis, 1985) , dopamine receptor (Stoof and Kebabian, 1984) , benzodiazapine receptor (Lo et al., 1982) , and serotonin receptor (Peroutka and Snyder, 1979) all have several subtypes defined by their different pharmacological properties. Adrenergic receptor subtypes have been especially well-characterized in terms of pharmacology, structure, and function (Stiles et al., 1983; Lomasney et al., 1986) . Heterogeneity of sodium channels of the nervous system has also been suggested electrophysiologically (Gundersen et al., 1983) , immunochemically (Wollner and Catterall, 1985) , and by molecular genetic techniques (Noda et al., 1986) .
The role of the 2 AChR subtypes in chicken brain is not yet known. Immunohistochemically, we have demonstrated that in the Zebra finch brain (Podleski et al., 1986 ) and the chicken brain (Swanson et al., 1987) these AChR subtypes are located in different regions of the brain. As we have speculated above, the p subunits of these AChRs may differ by a domain that is involved in neither ligand binding nor cation channel function, but rather in interaction with cytoskeletal or extracellular elements involved in AChR localization or turnover. Or this domain might be involved in alternate signaling by or regulation of these AChRs. It is possible that one of the subtypes is a postsynaptic AChR, while the other is presynaptic, modulating the release of ACh or another neurotransmitter. In PC12 cells these AChRs modulate the release of ACh (T. Rogers, personal communication), catecholamines (Mizobe and Livett, 1983) enkephalins (Eiden et al., 1984) and dopamine (Baizer and Weiner, 1985) . Immunohistochemical techniques provide strong evidence that at least some of the AChRs in rat brain bound bv mAb 270 are presynaptic (Swanson et al., 1987) . mAbs will prove useful tools in localizing, identifying the cDNAs for, and determining the functional roles of neuronal AChR subtypes.
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